0001209191-21-067491.txt : 20211202 0001209191-21-067491.hdr.sgml : 20211202 20211202141659 ACCESSION NUMBER: 0001209191-21-067491 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lecault Veronique CENTRAL INDEX KEY: 0001834418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 211466012 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-30 0 0001703057 AbCellera Biologics Inc. ABCL 0001834418 Lecault Veronique C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA 1 1 0 0 Chief Operating Officer Common Shares 2021-11-30 4 M 0 83333 14.96 A 1422666 D Common Shares 7155008 I See Footnote Common Shares 273630 I See Footnote Common Shares 61580 I By spouse Share Option (right to buy) 0.19 2021-11-30 4 M 0 83333 0.00 D 2027-03-23 Common Shares 83333 2774134 D These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein. These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein. The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Tryn Stimart, attorney-in-fact 2021-12-02